National Center Of Neurology And Psychiatry competitive analysis

Loading summary...

Explore National Center Of Neurology And Psychiatry's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
Aug 7, 2019Antisense Nucleic Acids2

Latest publications and patents of National Center Of Neurology And Psychiatry New

Explore the latest publications and patents granted to National Center Of Neurology And Psychiatry, showcasing their recent innovations and technological advancements.

Last updated on: Oct 20, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of National Center Of Neurology And Psychiatry

Aug 20, 2025Prophylactic Agent, Onset-Suppressing Agent Or Therapeutic Agent For Progressive Immune Demyelinating DiseasesGranted And Under Opposition
Aug 7, 2019Antisense Nucleic AcidsRevoked

Latest PTAB cases involving National Center Of Neurology And Psychiatry

Discover the latest PTAB cases involving National Center Of Neurology And Psychiatry, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing National Center Of Neurology And Psychiatry with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
NATIONAL CENTER OF NEUROLOGY AND PSYCHIATRY - 2 - 7
JAMES POOLE153 - - -
SAREPTA THERAPEUTICS1 - 10 -